Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jill Rillema"'
Autor:
Philip M. Wallace, Jill Rillema, Jingpeng Peng, Samuel A. Burstein, Mohammed Shoyab, John F. MacMaster
Publikováno v:
Blood. 86:1310-1315
Oncostatin M (OM) is a 28-kD glycoprotein that exhibits a panoply of biologic effects. Based on histologic observations of increased splenic megakaryocytes in nude mice implanted with an OM-secreting cell line, the thrombocytopoietic properties of OM
Autor:
Valentina Ciccarone, Farha Vasanwala, Doug Smith, Xiao-Tao Yao, Sergey Gorlatov, Leilei He, Monica Licea, Ezio Bonvini, Francine Chen, James Tamura, Jennifer R. Brown, Kalpana Shah, Jill Rillema, Ross LaMotte-Mohs, Wei Chen, Syd Johnson, Scott Koenig, Jeffrey L. Nordstrom, Paul Moore, Hua Li
Publikováno v:
Cancer Research. 76:3217-3217
Introduction: The combination of monoclonal antibodies (mAbs) that targets the immune checkpoint molecules CTLA-4 and PD-1 has shown clinical benefit beyond that observed with either mAb alone. This finding has prompted exploring whether such an appr
Autor:
Ralph Alderson, Ezio Bonvini, Syd Johnson, Annie Lam, James Tamura, Jill Rillema, Paul Moore, Doug Smith, Shereen Saini-Lal, Francine Chen, Monica Licea, Liqin Liu, Yinhua Yang
Publikováno v:
Cancer Research. 76:1498-1498
Introduction. IL13Rα2 is a membrane-bound protein expressed on a number of malignant tumors, but not at significant levels in most normal tissues. Clinically tested therapies to treat cancer by targeting IL13Rα2 to date have included a ligand toxin
Autor:
Sergey Gorlatov, Doug Smith, Ezio Bonvini, Syd Johnson, Kalpana Shah, James Tamura, Francine Chen, Paul A. Moore, Steve Burke, Jill Rillema, Ralph Alderson, Valentina Ciccarone, Jonathan C. Li
Publikováno v:
Cancer Research. 75:2464-2464
Introduction: Death Receptor 5 (DR5) belongs to the tumor necrosis factor receptor superfamily. The target and its associated signaling pathway are preferentially active on cancer cells. DR5 elicits pro-apoptotic signal through receptor oligomerizati
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Katherine A. Rouleau, Mohammed Shoyab, Jill Rillema, Samuel A. Burstein, Philip M. Wallace, John F. MacMaster, Hanson Marcia B
Publikováno v:
Annals of the New York Academy of Sciences. 762
Autor:
Steve Burke, Francine Chen, Sergey Gorlatov, Valentina Ciccarone, Syd Johnson, Hua Li, Thomas Son, Wenjun Zhang, Paul Moore, Ezio Bonvini, Jonathan Yu-Meng Li, Y Chen, Ralph Alderson, Stanford J. Stewart, Tony W. Liang, Yinhua Yang, Ling Huang, Deryk T. Loo, Scott Koenig, Jill Rillema, Jennie P. Mather, Monica Licea
Publikováno v:
Cancer Research. 72:2725-2725
Antigens that are tumor-specific or over-expressed on cancer cells represent opportunities for developing target-specific antibody-based therapeutics. Utilizing a non-target-biased intact cell-based immunization approach, we have generated greater th